We thought this article was worth communicating further as the issues McNeil have experienced may be impacting the packaging/products for other companies.
Annie Dallison
FDA has issued a warning letter to McNeil Healthcare stating that its Jan. 8 inspection of the company’s Las Piedras, Puerto Rico, location identified significant cGMP violations. Since 2008, McNeil has received odor complaints regarding certain Tylenol products. In 2009, McNeil began recalling bottled OTC products after discovering that packaging may have been contaminated with a pallet pesticide. The recall now numbers 60 million bottles.
Felix says:
arthur says: